| Product Code: ETC10070431 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market - Industry Life Cycle |
3.4 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market - Porter's Five Forces |
3.5 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.7 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Population Type, 2021 & 2031F |
3.8 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Vietnam |
4.2.2 Growing awareness about the side effects of chemotherapy-induced nausea and vomiting |
4.2.3 Rising healthcare expenditure and government initiatives to improve cancer care |
4.3 Market Restraints |
4.3.1 Limited access to advanced chemotherapy drugs in certain regions of Vietnam |
4.3.2 High cost associated with chemotherapy-induced nausea and vomiting drugs |
4.3.3 Stringent regulatory requirements for drug approval in Vietnam |
5 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Trends |
6 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market, By Types |
6.1 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Acute Emesis, 2021- 2031F |
6.1.4 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Delayed Emesis, 2021- 2031F |
6.1.5 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Anticipatory Emesis and Refractory Emesis, 2021- 2031F |
6.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market, By Therapy |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Nk-1 Receptor Antagonist, 2021- 2031F |
6.2.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Serotonin Receptor Antagonist, 2021- 2031F |
6.2.4 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market, By Population Type |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Childrens, 2021- 2031F |
6.3.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Adults, 2021- 2031F |
6.4 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market, By Drug Type |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Generics, 2021- 2031F |
6.5 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.6.5 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Import-Export Trade Statistics |
7.1 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Export to Major Countries |
7.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Imports from Major Countries |
8 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Key Performance Indicators |
8.1 Patient-reported outcomes related to nausea and vomiting management |
8.2 Adoption rate of antiemetic guidelines by healthcare facilities |
8.3 Percentage of healthcare professionals trained in chemotherapy-induced nausea and vomiting management |
9 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market - Opportunity Assessment |
9.1 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.3 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Population Type, 2021 & 2031F |
9.4 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.5 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market - Competitive Landscape |
10.1 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Chemotherapy Induced Nausea and Vomiting Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here